These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25044780)

  • 1. Cognition in breast cancer survivors: hormones versus depression.
    Seliktar N; Polek C; Brooks A; Hardie T
    Psychooncology; 2015 Apr; 24(4):402-7. PubMed ID: 25044780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy.
    Calhoun C; Helzlsouer KJ; Gallicchio L
    J Psychosoc Oncol; 2015; 33(3):263-77. PubMed ID: 25751493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study.
    Ganz PA; Petersen L; Castellon SA; Bower JE; Silverman DH; Cole SW; Irwin MR; Belin TR
    J Clin Oncol; 2014 Nov; 32(31):3559-67. PubMed ID: 25267747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study.
    Chang CH; Chen SJ; Liu CY
    J Affect Disord; 2015 Aug; 182():44-9. PubMed ID: 25973782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential factors associated with perceived cognitive impairment in breast cancer survivors.
    Myers JS; Wick JA; Klemp J
    Support Care Cancer; 2015 Nov; 23(11):3219-28. PubMed ID: 25832894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
    Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
    Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
    Bedillion MF; Ansell EB; Thomas GA
    Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
    Le Rhun E; Delbeuck X; Lefeuvre-Plesse C; Kramar A; Skrobala E; Pasquier F; Bonneterre J
    Breast Cancer Res Treat; 2015 Aug; 152(3):569-80. PubMed ID: 26160250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
    Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal adjuvant endocrine therapy for early breast cancer.
    Stuart-Harris R; Davis A
    Womens Health (Lond); 2010 May; 6(3):383-98. PubMed ID: 20426605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of side effects related to adjuvant hormone therapy in young women with breast cancer].
    Saghatchian M; Lesur A
    Bull Cancer; 2019 Dec; 106(12S1):S37-S42. PubMed ID: 32008736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of childhood trauma exposure and cortisol levels on cognitive functioning among breast cancer survivors.
    Kamen C; Scheiber C; Janelsins M; Jo B; Shen H; Palesh O
    Child Abuse Negl; 2017 Oct; 72():163-171. PubMed ID: 28818733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.
    Phillips KA; Ribi K; Sun Z; Stephens A; Thompson A; Harvey V; Thürlimann B; Cardoso F; Pagani O; Coates AS; Goldhirsch A; Price KN; Gelber RD; Bernhard J
    Breast; 2010 Oct; 19(5):388-95. PubMed ID: 20385495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic consequences of breast cancer adjuvant hormonal treatments.
    Pezzin LE; O'Niel MB; Nattinger AB
    J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S446-50. PubMed ID: 19838848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
    Wheler J; Johnson M; Seidman A
    Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.